Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-07-18
2006-07-18
Ungar, Susan (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S387700, C530S388260, C530S388800, C530S389100, C530S389700
Reexamination Certificate
active
07078491
ABSTRACT:
The present invention relates to novel selective binding agents including polyclonal and monoclonal antibodies that recognize and bind to the catalytic subunit of human telomerase (hTERT). The invention also relates to the production, diagnostic use, and therapeutic use of the hTERT antibodies and fragments thereof.
REFERENCES:
patent: 990701 (2000-04-01), None
patent: WO 96/19580 (1996-06-01), None
patent: WO 98/14592 (1998-04-01), None
patent: WO 98/14593 (1998-04-01), None
patent: 98/37181 (1998-08-01), None
patent: WO 99/01560 (1999-01-01), None
patent: WO 99/27113 (1999-06-01), None
patent: WO 99/50407 (1999-10-01), None
Gura (Science, 1997, 278:1041-1042).
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, NY, p. 4).
Pluckthun (Immunological Reviews, 1992, 19:151-188).
Dermer (Bio/Technology, 1994, 12:390).
Johnstone and Thorpe (Immunochemistry in Practice, Blackwell Scientific Publications, Oxford, 1987, pp. 49-50).
Beattie et al., Reconstitution of Human Telomerase Activityin vitro, Curr. Biol., 8:177-80 (1998).
Blasco et al., Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA,Cell, 91:25-34 (1997).
Blasco et al., Differential Regulation Of Telomerase Activity and Telomerase RNA During Multi-Stage Tumorigenesis,Nature Genetics, 12:200-204 (1996).
Bodner et al., Extension of Life-Span by Introduction of Telomerase into Normal Human Cells,Science279:349-352 (1998).
Chiu et al., Differential Expression of Telomerase Activity in Hematopoietic Progenitors from Adult Human Bone Marrow,Stem Cells, 14:239-248 (1996).
Greenberg et al., Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4a⅔Cancer-Prone Mouse,Cell, 97:515-525 (1999).
Greider et al., Telomeres and Telomerase in Cell Senescence and Immortalization,in Cellular Aging and Cell Death, Wiley-Liss Inc., New York, NY, pp. 123-138 (1996).
Greider, Telomere Length Regulation,Annu. Rev. Biochem., 65:337-365 (1996).
Hahn et al., Inhibition of Telomerase Limits the Growth of Human Cancer Cells,Nat. Med., 5:1164-1170 (1999).
Harley et al., Telomeres Shorten During Ageing of Human Fibroblasts,Nature, 345:458-460 (1990).
Harley et al., Telomerase, Cell Immortality, and Cancer,Cold Spring Harbor Symposium on Quantitative Biology, 59:307-315 (1994).
Harrington et al., Human Telomerase Contains Evolutionarily Conserved Catalytic And Structural Subunits,Genes and Dev., 11:3109-3115 (1997).
Herbert et al., Inhibition of Human Telomerase in Immortal Human Cells Leads To Progressive Telomere Shortening and Cell Death,Proc. Natl. Acad. Sci., 96:14276-14281 (1999).
Kilian et al., Isolation of a Candidate Human Telomerase Catalytic Subunit Gene, Which Reveals Complex Splicing Patterns in Different Cell Types,Hum. Mol. Gen., 6:2011-2019 (1997).
Kohler et al., Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity,Nature, 256:495-497 (1975).
Lendvay et al., Senescence Mutants ofSaccharomyces cerevisiaewith a Defect in Telomere Replication Identify Three Additional EST Genes,Genetics, 144:1399-1412 (1996).
Levy et al., Telomere End-replication Problem and Cell Aging,J. Mol. Biol., 225:951-960 (1992).
Lingner et al., Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase,Science, 276:561-567 (1997).
Meyerson et al., hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization,Cell, 90:785-795 (1997).
Nakamura et al., Telomerase Catalytic Subunit Homologs from Fission Yeast and Human,Science, 277: 955-959 (1997).
Nakayama et al., Telomerase Activation By hTRT In Human Normal Fibroblasts and Hepatocellular Carcinomas,Nature Gen., 18: 65-68 (1998).
Ogoshi et al.,In SituHybridization Analaysis of the Expression of Human Telomerase RNA in Normal and Pathologic-Conditions of the Skin,J. Invest. Dermatol., 110:818-23 (1998).
Oulton et al., Telomeres, Telomerase, and Cancer: Life of the Edge Of Genomic Stability,Curr. Opin. in Oncol., 12: 74-81 (2000).
Robinson et al., Telomerase: A Reverse Transcriptase Essential for Genome Stability,Biotech. Med., 12:6-9 (1998).
Taylor et al., Detection of Telomerase Activity in Malignant and Nonmalignant Skin Conditions,J. Invest. Dermatol. 106:759-765 (1996).
Vaziri et al., Reconstitution of Telomerase Activity in Normal Human Cells Leads To Elongation of Telomeres and Extended Replicative Life Span,Curr. Biol., 8: 279-282 (1998).
Weinrich et al., Reconsitution of Human Telomerase with the Template RNA Component hTR and the Catalytic Protein Subunit hTRT,Nat. Gen., 17: 498-502 (1998).
Zakian, Life and Cancer Without Telomerase,Cell, 91:1-3 (1997).
Zhang et al., Telomere Shortening And Apoptosis In Telomerase-Inhibited Human Tumor Cells,Genes Dev., 13: 2388-2399 (1999).
Amgen Inc.
Marshall & Gerstein & Borun LLP
Ungar Susan
LandOfFree
Selective binding agents of telomerase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective binding agents of telomerase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective binding agents of telomerase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3542265